作者: Mark J. Tomishima , Lorenz Studer
DOI: 10.1016/B978-0-12-374028-1.00035-X
关键词:
摘要: Publisher Summary This chapter explores uses of embryonic stem cells (ESCs) aimed at modeling Parkinson's disease in vitro. ES-derived mDA neurons provide a number advantages over embryo-derived neurons. One the main is unlimited supply ES-based differentiations can be scaled up to required ESCs are pluripotent, meaning they differentiate into wide range cell types, and therefore PD-related genotype differentiated many different types develop any adult organism, such as case mouse ESCs. Genetically modified introduced developing embryo subject partial (chimera) or complete (tetraploid aggregation). Another advantage using ability precisely alter genome karotypically normal cells. An approach for genetic modification with use conventional, plasmid-based transgenes whereby promoter–gene–polyadenylation cassette randomly integrated ESC genome. ESC-based DA also an ideal substrate large-scale, high-throughput screens.